Tongling Jieya Biologic Technology Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 970.23 million compared to CNY 737.73 million a year ago. Revenue was CNY 984.45 million compared to CNY 743.01 million a year ago. Net income was CNY 220.05 million compared to CNY 179.63 million a year ago. Basic earnings per share from continuing operations was CNY 3.52 compared to CNY 2.95 a year ago. Diluted earnings per share from continuing operations was CNY 3.52 compared to CNY 2.95 a year ago.